Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Cboe UK CHF

Clariant AG (CLNZ.XC)

Compare
10.62
+0.35
+(3.41%)
At close: March 14 at 4:19:30 PM GMT
Loading Chart for CLNZ.XC
  • Previous Close 10.27
  • Open 10.38
  • Bid 10.62 x --
  • Ask 10.63 x --
  • Day's Range 10.32 - 10.74
  • 52 Week Range 9.24 - 15.06
  • Volume 310,242
  • Avg. Volume 241,655
  • Market Cap (intraday) 3.492B
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) 29.50
  • EPS (TTM) 0.36
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 0.42 (3.95%)
  • Ex-Dividend Date May 30, 2024
  • 1y Target Est --

Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal care, coatings, adhesives, and agriculture, and food. The Catalysis segment provides the business services for propylene and ethylene, syngas and fuels, and specialties. The Adsorbents and Additives segment provides coatings, adhesives and polymer solutions for home care, personal care, coatings, adhesives, agriculture, food, electrics, electronics, automotive, oil, building, construction, aviation, and mining. The company was founded in 1886 and is headquartered in Muttenz, Switzerland.

www.clariant.com

10,465

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLNZ.XC

View More

Performance Overview: CLNZ.XC

Trailing total returns as of 3/14/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD .

YTD Return

CLNZ.XC
5.67%
MSCI WORLD
1.33%

1-Year Return

CLNZ.XC
6.48%
MSCI WORLD
8.05%

3-Year Return

CLNZ.XC
41.78%
MSCI WORLD
0.00%

5-Year Return

CLNZ.XC
31.38%
MSCI WORLD
95.02%

Compare To: CLNZ.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLNZ.XC

View More

Valuation Measures

Annual
As of 3/14/2025
  • Market Cap

    3.50B

  • Enterprise Value

    5.14B

  • Trailing P/E

    29.50

  • Forward P/E

    10.95

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    1.60

  • Enterprise Value/Revenue

    1.24

  • Enterprise Value/EBITDA

    9.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.88%

  • Return on Assets (ttm)

    3.89%

  • Return on Equity (ttm)

    11.94%

  • Revenue (ttm)

    4.15B

  • Net Income Avi to Common (ttm)

    244M

  • Diluted EPS (ttm)

    0.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    395M

  • Total Debt/Equity (mrq)

    75.12%

  • Levered Free Cash Flow (ttm)

    98.75M

Research Analysis: CLNZ.XC

View More

Company Insights: CLNZ.XC

Research Reports: CLNZ.XC

View More

People Also Watch